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The insulin/TOR signaling pathway plays a crucial
role in animal homeostasis, sensing nutrient status
to regulate organismal growth and metabolism. We
identify here the Drosophila B0 regulatory subunit of
PP2A (PP2A-B0) as a novel, conserved component
of the insulin pathway that specifically targets the
PP2A holoenzyme to dephosphorylate S6K. PP2A-
B0 knockout flies have elevated S6K phosphorylation
and exhibit phenotypes typical of elevated insulin
signaling such as reduced total body triglycerides
and reduced longevity. We show that PP2A-B0 inter-
acts with S6K both physically and genetically. The
human homolog of PP2A-B0, PPP2R5C, also coun-
teracts S6K1 phosphorylation, indicating a con-
served mechanism in mammals. Since S6K affects
development of cancer and metabolic disease, our
data identify PPP2R5C as a novel factor of potential
medical relevance.
INTRODUCTION
Insulin signaling is an evolutionarily conserved pathway crucial
for the proper regulation of growth, metabolism, and longevity
in animals (Goberdhan and Wilson, 2003; Taguchi and White,
2008). Insulin signaling is highly conserved from mammals to
flies, both molecularly and in terms of the physiological pro-
cesses that it regulates (Grewal, 2009). Insulin signaling inte-
grates inputs from growth factors and nutrients to regulate
cellular metabolic pathways so that the proper organismal bal-
ance of nutrient/energy expenditure versus storage is achieved.
Dysregulation of insulin signaling in humans contributes to
disease, as hyperactivation of the pathway is observed in almost
all cancers (Hafen, 2004), and reduced activation is associated
with diabetes and obesity (Goberdhan and Wilson, 2003).
(Although there are multiple connections between insulin and
TOR signaling, the significance of these connections is currently
an issue of debate. We use here the term ‘‘insulin signaling’’ in438 Cell Metabolism 11, 438–444, May 5, 2010 ª2010 Elsevier Inc.a broad sense, denoting insulin signaling and TOR signaling
combined.)
In order to maintain organismal energy homeostasis, insulin
signaling needs to respond to changing nutrient conditions,
both rapidly increasing and decreasing its state of activation as
necessary. The insulin pathway contains a large number of
kinases that activate each other through a relay of phosphoryla-
tion events upon binding of insulin to its receptor. This gives
a molecular explanation for activation of the pathway; however,
the fact that the pathway can also be inactivated suggests phos-
phatases exist to counteract the various kinases.
S6K is an important effector of the insulin/TOR pathway
inducing ribosome biogenesis, enhancing translation of mRNAs
containing structured 50UTRs and inhibiting apoptosis (Hay and
Sonenberg, 2004). As a consequence, S6K promotes cell growth
and proliferation, contributing to the development of cancer
(Jastrzebski et al., 2007), and plays an important role in the
regulation of organismal metabolism (Um et al., 2004). Thus,
the precise regulation of S6K activity is critical for normal animal
growth and homeostasis. Activation of S6K has been extensively
studied and occurs via phosphorylation by TOR and PDK1, thus
integrating nutrient availability and growth factor signaling (Jastr-
zebski et al., 2007). Dephosphorylation of S6K is less well under-
stood. Inhibition of TOR causes S6K to become dephosphory-
lated within minutes, despite S6K protein levels remaining
unchanged (Bielinski and Mumby, 2007), suggesting that a phos-
phatase dephosphorylates S6K.
We identify here PP2A-B0 (CG7913), encoding a regulatory B0
subunit of PP2A, as a specific negative regulator of S6K phos-
phorylation. PP2A-B0 knockout flies have elevated levels of
S6K phosphorylation. They display significant metabolic aberra-
tions, which are rescued by reducing S6K gene dosage.
We show that PP2A-B0 mutants lose robustness to nutritional
variation, highlighting an important role of PP2A-B0 in the main-
tenance of organismal homeostasis. Knockdown of the human
PP2A-B0 homolog PPP2R5C in cells also affects S6K phosphor-
ylation, implying functional conservation of this regulatory
subunit in humans. Although the catalytic subunit of PP2A has
been implicated in the dephosphorylation of S6K in cell culture
(Ballou et al., 1988; Bielinski and Mumby, 2007), its function is
highly pleiotropic, accounting for a large fraction of phosphatase
activity in eukaryotic cells (Millward et al., 1999). The discovery of
Cell Metabolism
PP2A-B0 Dephosphorylates S6Ka regulatory subunit targeting PP2A activity specifically to S6K
opens the possibility of using it for diagnostic or therapeutic
purposes.
RESULTS
PP2A-B0 Knockout Flies Are Lean and Short Lived
To study the function of PP2A-B0, we created PP2A-B0 knockout
flies by replacing the first exon common to all splice variants with
the miniwhite gene by homologous recombination (Figure 1A)
(Gong and Golic, 2003). This leads to premature disruption of
the coding sequence and a shift in the reading frame of remain-
ing exons, generating a null mutation. To clean the genetic back-
ground of knockout flies, females heterozygous for the knockout
mutation were backcrossed to w1118 flies, an inbred but not
isogenic laboratory stock. After four generations of backcross-
ing, stocks were established from single males, yielding two
independent knockout lines, KO1 and KO2.
KO1 flies are viable to adulthood (Figure 1B), normal in devel-
opmental rate (Figure 1C), and almost normal in size (Figure 1D,
see Figures S1A and S1B online). To test whether PP2A-B0
affects fly metabolism, we measured total body triglycerides,
normalized to total body protein, of KO1 and w1118 control flies
grown under controlled nutrient and density conditions. PP2A-
B0 mutants are strikingly lean, containing 28% of the triglyceride
levels of w1118 controls (Figure 1E). This leanness is specific for
loss of PP2A-B0, as it is significantly rescued by expression of
PP2A-B0 from a transgene (Figure 1E). PP2A-B0 mutants also
contain roughly half as much total body glycogen as control flies
(Figure S1C). We also asked whether PP2A-B0 affects longevity
and found that KO1 flies have significantly reduced life span
compared to controls (Figure 1F).
We studied the effect of PP2A-B0 overexpression by gener-
ating UAS-PP2A-B0 transgenic lines and crossing them to
GAL4 drivers. Overexpression of PP2A-B0 with en-GAL4 caused
lethality with most UAS lines (data not shown). One weak UAS
line, however, gave viable adults with wing posterior compart-
ments—where en-GAL4 is expressed—that were normally
patterned but significantly reduced in size by 12% (Figure 1G).
Overexpression of PP2A-B0 in the head and eye using eyeless-
Gal4 also caused a reduction in tissue size, ranging in strength
from mild to strong (Figures 1H and 1H0). In summary, PP2A-B0
overexpression causes a reduction in tissue size or lethality.
PP2A-B0 Represses S6K Phosphorylation
The phenotypes described above suggested PP2A-B0 might
play a repressive role in insulin signaling. Flies with elevated
insulin signaling in the whole body by mutation of PTEN have
reduced lipid levels (Oldham et al., 2002), similar to PP2A-B0
mutants. Insulin signaling also regulates longevity (Taguchi and
White, 2008), and overactivation of S6K leads to reduced life
span (Kapahi et al., 2004), similar to PP2A-B0 mutants. Finally,
inhibition of insulin signaling leads to reduced tissue growth
(Goberdhan and Wilson, 2003), analogous to what we observe
with PP2A-B0 overexpression. Therefore, we asked whether
PP2A-B0 affects insulin signaling by assaying phosphorylation
of S6K, a direct target of TOR Complex 1 (TOR-C1) (Hay and
Sonenberg, 2004). Immunoblotting of protein extracts from
KO1 and control w1118 animals revealed that KO1 flies haveCsignificantly elevated levels of phosphorylated S6K (Figure 2A,
lanes 1 and 2). This effect was reversed by ubiquitous expression
ofPP2A-B0 from a transgene in the KO1 mutant background (Fig-
ure 2A, lane 3). Total levels of dERK are shown as loading
control, since work in our laboratory with other genes of the
insulin pathway has shown that tubulin levels can vary when
insulin signaling is modulated (data not shown).
We asked at what level of the insulin pathway PP2A-B0 might
be functioning by detecting the state of activation of other
components of the pathway. We assayed phosphorylation of
Akt on the site for which antibodies are available (S505) and
found that it was unaffected in KO1 animals compared to
controls (Figure 2B). We also assayed activity of the transcription
factor FOXO, which is regulated via phosphorylation by Akt and
is a sensitive readout for Akt activation (Puig et al., 2003). Quan-
titative RT-PCR on RNA extracted from KO1 and control w1118
animals revealed no difference in mRNA levels of a well-charac-
terized FOXO target, 4E-BP (Figure 2C) (Teleman et al., 2005).
These data indicate that activation of the pathway at the level
of Akt is not increased in PP2A-B0 mutants. If anything, we
observed slightly reduced Akt phosphorylation on dSer505/
mSer473 in PP2A-B0 loss-of-function conditions in vivo and in
cell culture (Figure 2D and Figure 4E, lanes 3 and 4). The only
kinase known to phosphorylate S6K on Thr398 in Drosophila
is TOR-C1. Therefore, increased phosphorylation of S6K in
PP2A-B0 knockout animals could be due to increased TOR-C1
activity. To test this, we assayed phosphorylation of another
direct target of TOR-C1, 4E-BP. 4E-BP phosphorylation was
not elevated in PP2A-B0 knockouts (Figure 2B), indicating that
elevated levels of S6K phosphorylation in KO1 animals are not
due to increased TOR-C1 activity. Together, these results
suggest PP2A-B0 acts specifically at the level of S6K.
The Human PP2A-B0 Homolog PPP2R5C Represses
S6K1 Phosphorylation
Since the insulin pathway is highly conserved from flies to hu-
mans, we asked whether the human homologs of dPP2A-B0
also affect S6K phosphorylation. Alignment of human and Dro-
sophila PP2A-B0 regulatory subunits reveals that dPP2A-B0 is
most related to PPP2R5C and PPP2R5D (Figure S2A). Therefore,
we tested both PPP2R5C and PPP2R5D. While siRNA-mediated
knockdown ofPPP2R5D had no consistent effect on S6K1 phos-
phorylation, knockdown of PPP2R5C with two independent
siRNAs increased the amount of phosphorylated S6K protein
in HeLa cells (Figures 2D and 2E and Figure S2B). Total levels
of S6K1 protein were also elevated, perhaps as a secondary
consequence of S6K1 stabilization (Wang et al., 2008) (Figures
2D and 2E). As in Drosophila, phosphorylation of 4E-BP and
Akt were not increased (Figure 2D), indicating a specific effect
on S6K1.
PP2A-B0 Interacts with S6K In Vitro and In Vivo
The specific effect of PP2A-B0 on S6K raised the possibility that
PP2A-B0 might be acting directly on S6K. The regulatory
subunits of PP2A such as PP2A-B0 are thought to provide spec-
ificity to the PP2A holoenzyme by recruiting it to specific
substrates (Mumby, 2007). To test this, we asked whether
PP2A-B0 and S6K interact physically. We expressed FLAG-
tagged PP2A-B0 and HA-tagged S6K in S2 cells and precipitatedell Metabolism 11, 438–444, May 5, 2010 ª2010 Elsevier Inc. 439
Figure 1. PP2A-B0 Knockout Flies Are Lean
and Short Lived
(A) Overview of PP2A-B0 genomic locus, showing the
knockout region common to all splice forms.
(B–F) PP2A-B0 loss-of-function phenotypes. w1118
control flies (WT) and KO1 knockout flies (KO1) were
grown under controlled conditions on normal labora-
tory food at 25C. (B) PP2A-B0 knockout flies are
viable. Shown is percentage of live adults relative to
collected first-instar larvae. Error bars, standard devi-
ation (SD). (C) PP2A-B0 knockout flies are normal in
developmental rate. Pupation curves show per-
centage of pupated animals over time. Error bars,
SD (D) PP2A-B0 knockout flies are almost normal in
size. Shown is relative wing size of WT and KO1 flies.
Error bars, SD (E) PP2A-B0 knockout flies are lean.
Shown are relative triglyceride levels, normalized to
total body protein, for 5-day-old WT and KO1 flies,
as well as KO1 flies carrying either a UAS-PP2A-B0
transgene, a heat shock GAL4 transgene (hs-G4), or
both in order to express PP2A-B0 in the KO mutant
background. Error bars, SD. *t test = 3 3 104,
**t test = 0.01. (F) PP2A-B0 knockout flies have
reduced life span. Mean life spans of WT and KO1 flies
are 53.8 days (n = 97) and 38.5 days (n = 79), respec-
tively. On day 50, 68% of WT and 8% of KO1 flies
were alive (t test = 104). Done in triplicate. Error
bars, SD.
(G–H0) PP2A-B0 overexpression reduces tissue size.
(G) Posterior/anterior wing compartment size ratio of
engrailed-GAL4 (‘‘enG4’’) control or enG4 > PP2A-B0
overexpressing flies. Error bars, SD. *t test = 109.
(H) Phenotypes of flies overexpressing PP2A-B0 using
eyeless-Gal4, ranging from a mild to a strong reduc-
tion in size. (H0) Quantification of observed pheno-
types from (H).
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Figure 2. PP2A-B0 Represses S6K Phos-
phorylation in Drosophila and Humans
(A) PP2A-B0 knockout animals have elevated
levels of phosphorylated S6K protein. w1118
control (WT), KO1, and KO1 animals ubiquitously
expressing PP2A-B0 using heat shock Gal4,
UAS-PP2A-B0 transgenes (‘‘rescue’’) were grown
under controlled conditions. Wandering third-
instar larval lysates were analyzed by immuno-
blotting for phospho-S6K and S6K protein as
indicated. ERK was used as loading control.
(B) PP2A-B0 knockouts have normal Akt and
4E-BP phosphorylation levels. Samples were
prepared and processed as in (A).
(C) PP2A-B0 knockout animals have normal FOXO
activity. mRNA levels of the FOXO target 4E-BP in
control (WT) and PP2A-B0 knockouts (KO1) were
measured by quantitative RT-PCR relative to
rp49. Error bars, SD.
(D) Knockdown of the mammalian PP2A-B0
homolog PPP2R5C, but not PPP2R5D, by siRNA
increases S6K phosphorylation in HeLa cells.
HeLa cells were transfected with Invitrogen nega-
tive control (control) or PPP2R5C or PPP2R5D
siRNAs. ERK was used as loading control.
PPP2R5C and PPP2R5D knockdown efficiency
was 80% in both cases at mRNA level, measured
by Q-RT-PCR.
(E) Densitometric quantification of phospho-S6K
and total S6K bands shown in (D).
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PP2A-B0 Dephosphorylates S6KPP2A-B0 with anti-FLAG antibody. S6K could be detected in the
FLAG immunoprecipitate (IP), suggesting PP2A-B0 and S6K
interact physically (Figure 3A). S6K could not be detected in
the FLAG IP in the absence of FLAG-PP2A-B0, demonstrating
specificity of the pull-down (Figure 3A, lane 1). The S6K protein
that coimmunoprecipitated with PP2A-B0 was found to be
dephosphorylated (Figure S3A), consistent with the PP2A holo-
enzyme having acted upon it. In line with PP2A-B0 and S6K inter-
acting physically, the two genes are coexpressed ubiquitously in
fly tissues (Figures S3B and S3C).
To test whether the PP2A-B0-containing holoenzyme can
dephosphorylate S6K directly in vitro, we expressed HIS-tagged
S6K in Drosophila S2 cells, purified it on a nickel column, and
eluted it with imidazole, yielding soluble, phosphorylated S6K
that could be used as substrate for in vitro dephosphorylation
assays. PP2A-B0 containing PP2A holoenzyme was purified
by immunoprecipitation with anti-FLAG antibody from flies
expressing FLAG-tagged PP2A-B0. As a control, we performed
in parallel an anti-FLAG immunoprecipitation from flies not
expressing FLAG-PP2A-B0. Whereas incubation of phospho-Cell Metabolism 11, 438–S6K with IP from control animals caused
no dephosphorylation of S6K (Figure 3B,
lanes 1 and 2), incubation with IP
from FLAG-PP2A-B0-expressing animals
caused strong and obvious dephosphor-
ylation of S6K (Figure 3B, lane 3).
We tested whether PP2A-B0 and S6K
interact genetically in vivo. If the pheno-
types of PP2A-B0 knockouts are due to
elevated S6K activity, they should be rescued by removing one
copy of S6K (KO1, S6K+/). Indeed, triglyceride and glycogen
levels of KO1, S6K+/ flies were significantly rescued compared
to KO1 flies (Figure 3C and Figure S1C). Removing one copy of
S6K also partially rescued the decreased life span of PP2A-B0
knockouts (Figure 3D). In summary, these results indicate that
PP2A-B0 and S6K interact physically and genetically.
PP2A-B0 Knockouts Are Sensitive to Nutrient Conditions
While studying the PP2A-B0 knockout flies, we realized that one
of thePP2A-B0 knockout lines, KO2, is semilethal when grown on
standard laboratory food, which is rich in carbohydrates. Eighty-
eight percent of KO2 animals die as pharate adults (Figure 4A).
Both KO1 and KO2 lines were generated by backcrossing
knockout flies for four generations to the w1118 stock, which is
an inbred but not isogenic reference stock in the lab. The fact
that KO2 is semilethal and KO1 is viable suggests the two lines
differ in their genetic backgrounds. Indeed, the semilethality of
KO2 flies could be completely rescued by changing the second
chromosomes in the KO2 stock (Figure S4). This indicates the444, May 5, 2010 ª2010 Elsevier Inc. 441
Figure 3. PP2A-B0 Interacts with S6K
In Vitro and In Vivo
(A) PP2A-B0 interacts physically with S6K in S2
cells. Anti-FLAG immunoprecipitates (IP) and total
lysates from S2 cells transfected to express HA-
dS6K, FLAG-PP2A-B0, or both were probed with
anti-FLAG and anti-HA antibodies. HA-dS6K can
be detected in the anti-FLAG IP only in the pres-
ence of FLAG-PP2A-B0.
(B) PP2A-B0 dephosphorylates S6K in vitro. Phos-
phorylated HIS-tagged S6K purified from S2 cells
was incubated with buffer (–), anti-FLAG IP from
w1118 flies (control), or anti-FLAG IP from flies
expressing FLAG-PP2A-B0 (hs > FLAG-PP2A-B).
Phosphorylation and total levels of S6K were
analyzed by Western blotting.
(C) Removal of one copy of S6K partially rescues
the leanness of KO1 flies. Relative triglyceride
levels, normalized to total body protein, of
5-day-old w1118 flies (WT), KO1 flies, and KO1 flies
lacking one copy of S6K (KO, S6K+/). Animals
were grown under controlled conditions. Error
bars, SD. *t test% 0.005.
(D) Removal of one copy of S6K partially rescues
the shortened life span of KO1 flies. Mean life
span of WT, KO1, and KO1, S6K+/ flies was
45.2 days, 35.9 days, and 39.6 days, respectively.
On day 37, 51% of KO1 flies were still alive com-
pared to 77% of KO1, S6K+/ flies (t test = 0.03).
Done in triplicate. Error bars, SD.
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PP2A-B0 mutation on the third chromosome and genetic ele-
ments on the second chromosome. It is becoming increasingly
clear that genetic background plays an important role in modu-
lation of complex phenotypes and in development of diseases
such as diabetes or cancer (Adamo and Tesson, 2008). This is
well known in mice, for instance, where mutation of leptin (Lepob)
in the C57BL/6J background causes transient hyperglycemia,
subsiding 14–16 weeks of age, whereas the same mutation in
the C57BLKS/J background causes severe diabetes with
regression of islets and early death (Davis et al., 2005). Since
one genetic background is not more ‘‘correct’’ than another,
we decided to also study the KO2 flies. We first tested whether
KO2 flies have the same metabolic and biochemical phenotypes
as KO1 flies. KO2 animals, like KO1 animals, are lean (Figure 4B)
and have elevated levels of S6K phosphorylation (Figure 4C).
These results show that KO2 animals have the same metabolic
and biochemical phenotypes as KO1 animals, except that they
exhibit poor survival, indicating a more aggravated phenotype.
If the poor survival rate of KO2 flies is due to a combined
effect of elevated S6K activation and other genetic background
effects, reducing S6K phosphorylation by reducing insulin
signaling should rescue them. We tested this by rearing animals
on normal food (100% food) or on food diluted 1:5 with PBS/
agarose to make it less rich (20% food). Animals growing on
20% food take several additional days to pupate compared to
animals on 100% food, reflecting the lower richness of 20%
food (data not shown), and accordingly have reduced expression
of nutrient-responsive insulin-like peptides 2 and 5 (Figure 4D)
(Ikeya et al., 2002; Teleman et al., 2008). Consistent with this,
animals growing on 20% food have reduced intracellular insulin442 Cell Metabolism 11, 438–444, May 5, 2010 ª2010 Elsevier Inc.signaling compared to animals on 100% food, assayed by phos-
phorylation of Akt and S6K (Figure 4E). On 20% food, levels of
phospho-S6K in KO2 animals are still higher than in control flies
(Figure 4E, lanes 3 and 4), consistent with phospho-S6K levels
reflecting a balance of dephosphorylation by the PP2A/PP2A-
B0 holoenzyme and nutrient-responsive phosphorylation by
TOR. We then determined the survival rate of control and KO2
animals reared on 100% and 20% food. Intriguingly, on 20%
food the survival of KO2 flies was significantly improved (Fig-
ure 4F). These results indicate that, unlike control flies, KO2 flies
are sensitive to the nutritional overload of our rich laboratory
food. This is particularly striking since 20% food is normally
a stress condition for flies but results in improved viability here.
DISCUSSION
PP2A-B0 Counteracts S6K Phosphorylation
One reason phosphatases have been difficult to study is that
they often act pleiotropically. Blocking their activity usually leads
to multiple concurrent molecular effects and often lethality.
The phosphatase PP2A is a case in point; it accounts for a large
fraction of phosphatase activity in eukaryotic cells (Millward
et al., 1999), and mutation of the PP2A catalytic subunit leads
to lethality (Gotz et al., 1998). The PP2A active core dimer asso-
ciates with a large number of possible B subunits that give it spe-
cificity by mediating interaction with specific targets (Mumby,
2007). Therefore, studies of the individual regulatory B subunits
are critical for teasing apart the various functions of PP2A.
We discover here the regulatory subunit of PP2A, PP2A-B0/
PPP2R5C, as a novel component of the insulin pathway, which
specifically directs PP2A to dephosphorylate S6K (Figure 2).
Figure 4. PP2A-B0 Knockout Flies Are Sensitive to Nutritional
Conditions
(A) A second independent PP2A-B0 knockout line (KO2) is semilethal.
Percentage of live adult flies relative to collected first-instar larvae. Error
bars, SD. *t test = 1016.
(B) Surviving KO2 adult flies are lean. Relative triglyceride levels, normalized to
total body protein for animals grown under controlled conditions on normal
laboratory food. Error bars, SD. *t test = 0.01.
(C) KO2 flies have elevated levels of S6K phosphorylation, but normal levels of
4E-BP and Akt phosphorylation, compared to WT. Wandering third-instar
lysates were analyzed by immunoblotting as indicated. ERK was used as
loading control.
(D–F) WT and KO2 animals were grown in parallel either on normal food (100%)
or on food diluted 1:5 with PBS/agarose (20%). (D) Limiting food supply
decreases insulin signaling in WT and KO2 animals. Quantitative RT-PCR of
ILP2 and ILP5 mRNA from WT and KO2 wL3 normalized to rp49. Error bars,
SD. (E) Nutrient deprivation lowers S6K phosphorylation in KO2 animals.
wL3 lysates were analyzed by Western blotting as indicated. (F) Survival of
KO2 flies is significantly increased when animals were reared on 20% food.
Shown is percentage of live adult flies relative to collected first-instar larvae.
Error bars, SD. *t test% 104.
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reduced longevity and reduced nutrient stores—are insulin
gain-of-function phenotypes in the fly (Kapahi et al., 2004;COldham et al., 2002) and are rescued by removal of one
copy of S6K (Figures 3C and 3D and Figure S1C). Recently,
the other B0 regulatory subunit, widerborst, and its correspond-
ing homolog pptr-1 in C. elegans were shown to target PP2A
to Akt (Padmanabhan et al., 2009; Vereshchagina et al., 2008),
indicating that both B0 subunits are dedicated to keeping activa-
tion of the insulin signaling pathway under control.
S6K also regulates tissue growth (Hay and Sonenberg, 2004).
Consistent with this, overexpression of PP2A-B0 both in the wing
and in the eye leads to a reduction in tissue size (Figures 1G and
1H), phenocopying S6K loss of function (Kozma and Thomas,
2002). Unexpectedly, PP2A-B0 knockout flies are not larger
than controls. One reason may be that S6K gain of function in
the fly gives surprisingly mild overgrowth (Radimerski et al.,
2002), suggesting S6K activity may not be limiting for fly growth
under normal circumstances. Another reason may be that larval
and imaginal tissues compete for nutrients during development
and therefore the relative balance of PP2A-B0 activity in various
tissues might be important. Future work may shed more light
on this issue.
Flies mutant for PP2A-B0, called well-rounded, were recently
reported with mild defects in the number and size of boutons
at neuromuscular junctions (Viquez et al., 2006). TOR and S6K
play a variety of roles in neuronal growth, differentiation, and
dentritic growth and arborization. Whether repression of S6K
phosphorylation by PP2A-B0 plays a role in this context remains
to be investigated.
PP2A-B0 Is Required for Robustness
to Nutritional Variation
Signaling through the insulin pathway is both activated and
inactivated in a tightly controlled and rapid fashion, assuring
adequate and timely responses to varying nutritional conditions.
We show here that phosphatases, and in particular PP2A-B0,
play a key role in maintaining this balance, as PP2A-B0 mutants
can become sensitive to nutritional status. The viability of KO2
flies varied dramatically depending on the richness of their
food (Figure 4F), in contrast to wild-type animals, which were
viable under a wide range of genetic backgrounds and nutritional
conditions.
PPP2R5C and Human Disease
Drosophila PP2A-B0 has two mammalian homologs, PPP2R5C
and PPP2R5D. Knockdown of PPP2R5C resulted in elevated
levels of phosphorylated S6K protein in human cells (Figures
2D and 2E), suggesting PPP2R5C is the human functional
homolog of PP2A-B0. Aberrant insulin and S6K signaling have
been implicated in the etiology of a number of human diseases,
including diabetes, obesity, and cancer (Hafen, 2004; Kozma
and Thomas, 2002). Therefore, it will be interesting to investigate
whether PPP2R5C, as a novel regulator of S6K phosphorylation,
plays a role in development of these diseases. Our data suggest
dPP2A-B0 is required for the organism to respond properly to
elevated nutrient conditions. Diseases such as diabetes and
obesity could be considered situations in which the ability of
insulin signaling to compensate for elevated nutrient supply
has been exceeded. Furthermore, S6K1, as one of the principal
effectors of TOR-mediated tissue growth, has been linked to
a number of cancers (Mamane et al., 2006). This raises theell Metabolism 11, 438–444, May 5, 2010 ª2010 Elsevier Inc. 443
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by inhibiting S6K1 phosphorylation. Indeed, PPP2R5C was iden-
tified in a screen for genes downregulated in malignant mela-
noma (Deichmann et al., 2001). Future work will shed further light
on links between PPP2R5C and diseases involving insulin
signaling, such as cancer and diabetes/obesity.
EXPERIMENTAL PROCEDURES
Expression Constructs, Fly Lines, and Metabolic Analyses
Detailed description of plasmid construction, oligos, and metabolic analysis is
found in the Supplemental Information. HA-S6K expression construct was
a kind gift from Duojia Pan. hs-Gal4, en-Gal4, eye-Gal4, and S6K07084 flies
were from Bloomington Stock Center.
Cell Culture, Transfection, IP, and Antibodies
A detailed description of cell-culturing conditions, IP, and antibodies is in the
Supplemental Information. Gene knockdown in HeLa cells was performed in
6-well dishes using 5 ml of Dharmafect reagent (Dharmacon) and 0.1 mM of
siRNAs (Dharmacon L-009433-00-005, L-009799-00-0005) or 0.07 mM of
siRNA (Ambion P/N 4390824) per 1.5 3 105 cells/well, for 3 or 2.5 days,
respectively. mRNA levels of target genes were reduced by 80%, quantified
by Q-PCR.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
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